Literature DB >> 36152264

Diaminobenzidine Photooxidation to Visualize Fluorescent Nanoparticles in Adhering Cultured Cells at Transmission Electron Microscopy.

Manuela Costanzo1, Manuela Malatesta2.   

Abstract

Visualizing nanoparticles made of organic material (e.g., polysaccharides, proteins, non-osmiophilic lipids) inside cells and tissues at transmission electron microscopy is a difficult task due to the intrinsic weak electron density of these nanoconstructs, which makes them hardly distinguishable in the biological environment. We describe here a simple protocol to apply photooxidation to fluorescently labeled nanoparticles administered to cultured cells in vitro. The conversion of the fluorescent signal into a granular electron-dense reaction product through light irradiation in the presence of diaminobenzidine makes the nanoparticles clearly visible at the ultrastructural level. Our procedure proved to be reliable with various fluorophores and may be applied to any cell type.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cytochemistry; Diaminobenzidine-DAB; Fluorophores; Nanomedicine; Nanoparticle uptake; Ultrastructure

Mesh:

Substances:

Year:  2023        PMID: 36152264     DOI: 10.1007/978-1-0716-2675-7_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  32 in total

Review 1.  Intracellular delivery of nanocarriers and targeting to subcellular organelles.

Authors:  Aditi Jhaveri; Vladimir Torchilin
Journal:  Expert Opin Drug Deliv       Date:  2015-09-11       Impact factor: 6.648

Review 2.  Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine.

Authors:  Nathan D Donahue; Handan Acar; Stefan Wilhelm
Journal:  Adv Drug Deliv Rev       Date:  2019-04-22       Impact factor: 15.470

Review 3.  How successful is nuclear targeting by nanocarriers?

Authors:  Salma N Tammam; Hassan M E Azzazy; Alf Lamprecht
Journal:  J Control Release       Date:  2016-03-16       Impact factor: 9.776

4.  Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes.

Authors:  V Guglielmi; F Carton; G Vattemi; S Arpicco; B Stella; G Berlier; A Marengo; F Boschi; M Malatesta
Journal:  Int J Pharm       Date:  2019-02-20       Impact factor: 5.875

Review 5.  Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.

Authors:  Yi-Nan Zhang; Wilson Poon; Anthony J Tavares; Ian D McGilvray; Warren C W Chan
Journal:  J Control Release       Date:  2016-01-13       Impact factor: 9.776

6.  Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells: evidence of a beneficial effect on myoblast fusion.

Authors:  Sylvie Poussard; Marion Decossas; Olivier Le Bihan; Stéphane Mornet; Grégoire Naudin; Olivier Lambert
Journal:  Int J Nanomedicine       Date:  2015-02-19

7.  On the pathway of cellular uptake: new insight into the interaction between the cell membrane and very small nanoparticles.

Authors:  Claudia Messerschmidt; Daniel Hofmann; Anja Kroeger; Katharina Landfester; Volker Mailänder; Ingo Lieberwirth
Journal:  Beilstein J Nanotechnol       Date:  2016-09-16       Impact factor: 3.649

Review 8.  Transmission electron microscopy for nanomedicine: novel applications for long-established techniques.

Authors:  Manuela Malatesta
Journal:  Eur J Histochem       Date:  2016-12-09       Impact factor: 3.188

9.  Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery.

Authors:  M Costanzo; F Carton; A Marengo; G Berlier; B Stella; S Arpicco; M Malatesta
Journal:  Eur J Histochem       Date:  2016-04-14       Impact factor: 3.188

Review 10.  Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.

Authors:  Josanne Sophia de Maar; Alexandros Marios Sofias; Tiffany Porta Siegel; Rob J Vreeken; Chrit Moonen; Clemens Bos; Roel Deckers
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.